Search research articles
Contact Us
Filters
Showing results (171-180 of 613) with videos related to
Page
of 62
Sort By:
Chemical Communications (Cambridge, England)
|
September 2, 2020
Cancer cell death using metabolic glycan labelling techniques
Sang-Hyun Park, Hyoje Jung, Hosoowi Lee, et al.
Virchows Archiv : an International Journal of Pathology
|
September 7, 2016
Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis
Wook Youn Kim, Ho Young Jung, Soo Jeong Nam, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 14, 2007
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung
Mi Seon Kwon, Seung-Hun Shin, Seon-Hee Yim, et al.
Experimental & Molecular Medicine
|
October 16, 2021
Human kidney organoids reveal the role of glutathione in Fabry disease
Jin Won Kim, Hyung Wook Kim, Sun Ah Nam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2011
MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma
Jin Ho Paik, Ji-Young Jang, Yoon Kyung Jeon, et al.
Virchows Archiv : an International Journal of Pathology
|
March 15, 2020
Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified
Sehui Kim, Dohee Kwon, Jiwon Koh, et al.
The Korean Journal of Internal Medicine
|
April 14, 2017
KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
Sehhoon Park, Ji-Yeon Kim, Se-Hoon Lee, et al.
Frontiers in Cell and Developmental Biology
|
March 25, 2024
Cellular abundance-based prognostic model associated with deregulated gene expression of leukemic stem cells in acute myeloid leukemia
Dong-Jin Han, Sunmin Kim, Seo-Young Lee, et al.
Cancer Medicine
|
August 4, 2023
A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
Seung Won Choi, Hyun Ae Jung, Hee-Jin Cho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2016
Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer
Junghoon Shin, Bhumsuk Keam, Miso Kim, et al.
Page
of 62
Search research articles
Search
Showing results (171-180 of 613) with videos related to
Sort By:
Page
of 62
Chemical Communications (Cambridge, England)
|
September 2, 2020
Cancer cell death using metabolic glycan labelling techniques
Sang-Hyun Park, Hyoje Jung, Hosoowi Lee, et al.
Virchows Archiv : an International Journal of Pathology
|
September 7, 2016
Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis
Wook Youn Kim, Ho Young Jung, Soo Jeong Nam, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 14, 2007
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung
Mi Seon Kwon, Seung-Hun Shin, Seon-Hee Yim, et al.
Experimental & Molecular Medicine
|
October 16, 2021
Human kidney organoids reveal the role of glutathione in Fabry disease
Jin Won Kim, Hyung Wook Kim, Sun Ah Nam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2011
MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma
Jin Ho Paik, Ji-Young Jang, Yoon Kyung Jeon, et al.
Virchows Archiv : an International Journal of Pathology
|
March 15, 2020
Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified
Sehui Kim, Dohee Kwon, Jiwon Koh, et al.
The Korean Journal of Internal Medicine
|
April 14, 2017
KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
Sehhoon Park, Ji-Yeon Kim, Se-Hoon Lee, et al.
Frontiers in Cell and Developmental Biology
|
March 25, 2024
Cellular abundance-based prognostic model associated with deregulated gene expression of leukemic stem cells in acute myeloid leukemia
Dong-Jin Han, Sunmin Kim, Seo-Young Lee, et al.
Cancer Medicine
|
August 4, 2023
A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
Seung Won Choi, Hyun Ae Jung, Hee-Jin Cho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2016
Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer
Junghoon Shin, Bhumsuk Keam, Miso Kim, et al.
Page
of 62